Author

admin

Browsing

Today’s pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry’s major underlying drivers — higher rates of cancer and chronic disease — are still at play and not expected to dissipate. The US reigns supreme…

Private specialty chemicals company Maverick Metals has raised US$19 million in a seed funding round led by Olive Tree Capital to accelerate the commercialization of its flagship lixiviant technology, LithX. Unlike traditional acid-based processes, LithX enables cost-effective, ambient temperature leaching of refractory ores like chalcopyrite, unlocking metals previously considered uneconomical…